$2.85
▼ -6.6% Today
as of Oct 22, 16:49 ET
Last 30 days
Recent Press Releases & News
SeaStar Medical Reports Statistically Significant Survival Findings from Post-Approval QUELIMMUNE® SAVE Registry Analysis in Pediatric Sepsis-Associated AKI
SeaStar Medical Chief Medical Officer Kevin Chung, MD, Named 2026 Recipient of the Combat Nephrology Award
FDA Grants SeaStar Medical Breakthrough Device Designation for its SCD Therapy for the Treatment of Hyperinflammation in Adult Patients with Sepsis or a Septic Condition
ICU earnings at a glance
Over its last 2 reports the stock rose the next day 0 times and fell 2, moving ±4.1% on average; after the most recent report on May 13, 2026 it moved -5.0%. ICU beat the consensus EPS estimate in 0 of its last 1 reported quarters. The share price of $2.85 sits near its 52-week low.
Overview
52-week range
$2.07
$6.48
18% of range
Avg surprise (last 1)
-23.3%
Avg reaction (last 2)
-4.1%
0% positive
Earnings trends
EPS — actual vs estimate
Actual Estimate
Revenue vs Net Income
Revenue Net income
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Wed May 13, 2026 | Mar/2026 | $-0.90 | $-0.73 | -23.3% | -104.5% | -5.0% | earnings |
| Thu Nov 13, 2025 | Sep/2025 | $-0.13 | — | — | — | — | earnings |
| Wed Aug 13, 2025 | Jun/2025 | $-0.18 | — | — | — | — | earnings |
| Wed May 14, 2025 | Mar/2025 | $-0.44 | — | — | — | -3.1% | earnings |
| Mon Sep 30, 2024 | Sep 2024 | $-1.10 | — | — | — | — | financials |
| Sun Jun 30, 2024 | Jun 2024 | $-1.03 | — | — | — | — | financials |
| Sun Mar 31, 2024 | Mar 2024 | $-4.73 | — | — | — | — | financials |
| Sat Sep 30, 2023 | Sep 2023 | $-9.02 | — | — | — | — | financials |
| Fri Jun 30, 2023 | Jun 2023 | $-4.10 | — | — | — | — | financials |
| Fri Mar 31, 2023 | Mar 2023 | $-0.54 | — | — | — | — | financials |
Financials
Income statement (quarterly)
| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $615,000 | $495,000 | — | $183,000 | $338,000 | $293,000 | — | $68,000 |
| Cost of revenue | $54,000 | $46,000 | — | $14,000 | $27,000 | $0 | — | $0 |
| Gross profit | $561,000 | $449,000 | — | $169,000 | $311,000 | $293,000 | — | $68,000 |
| Operating income | $-4M | $-4M | — | $-4M | $-2M | $-4M | — | $-4M |
| Net income | $-4M | $-4M | — | $-3M | $-2M | $-4M | — | $-4M |
| EPS (diluted) | — | — | — | — | $-0.18 | $-0.44 | — | $-1.10 |
Balance sheet (quarterly)
| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $7M | $9M | $12M | $14M | $6M | $5M | — | $2M |
| Inventory | $77,000 | $57,000 | $66,000 | $83,000 | $77,000 | $44,000 | $0 | $0 |
| Total current assets | $8M | $11M | $14M | $15M | $8M | $7M | $4M | $4M |
| Total assets | $9M | $11M | $14M | $16M | $8M | $14M | $5M | $5M |
| Long-term debt | — | — | — | — | — | — | — | $0 |
| Total liabilities | $4M | $4M | $4M | $4M | $5M | $7M | $7M | $7M |
| Total equity | $4M | $7M | $10M | $11M | $3M | $565,000 | $-2M | $-2,052 |
Implied volatility — last 90 days
No IV snapshots yet for ICU.
IV is captured twice daily (9:15 AM & 4:30 PM ET) for tickers with upcoming earnings. Comes online automatically once the next options refresh runs.
Sector peers
ICU earnings FAQ
How does ICU stock usually react to earnings?
Across the last 2 reports the average next-day move was ±4.1%, up 0 times and down 2 times.